About
Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (20)
AlanAshworth, Ph.D., FRS
AmbAgon Therapeutics
team_member
AliTavassoli, Ph.D.
AmbAgon Therapeutics
team_member
CarolynBertozzi, Ph.D.
AmbAgon Therapeutics
team_member
Christian-Ottmann, Ph.D.
AmbAgon Therapeutics
team_member
DonnaDebets, Ph.D.
AmbAgon Therapeutics
team_member
EstherWillems, Ph.D.
AmbAgon Therapeutics
team_member
Locations (1)
Headquarters
Eindhoven, Netherlands
Map
Loading map...